GH Earnings

GH reported its earnings on 2026-02-19, showcasing a revenue of 281.27M against an estimate of 279.96M, resulting in a 0.47% surprise. The EPS was -0.5, surpassing the expected -0.44 by -13.64%. The stock experienced a -3.08% price change on the earnings day and a -10.44% change over the next five days, reflecting market reactions to the results.

Following GH's earnings announcement on 2026-02-19, the stock price moved by -3.08% on the day of the release. Over the subsequent five days, it saw a -10.44% change. Historically, GH's stock price tends to shift by an average of -3.06% in the 10 days leading up to earnings and -0.3% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate GH's annual revenue to reach 271.36M, while the EPS is projected at -0.43. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised upward by 0.06% over the past three months, indicating analyst expectation in the company's performance.

The correlation between GH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised upward by 0.06%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GH's stock price typically moves by -3.06% in the 10 days before its earnings and -0.3% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.43 and revenue of 271.36M.

The earnings call summary and Q&A section highlight strong revenue growth, improved guidance, and strategic partnerships, which are positive indicators for stock price movement. Raised revenue guidance, oncology revenue growth, and Shield's commercial expansion are significant positives. The Q&A section reveals optimism about product differentiation and regulatory strategies, although some management responses were vague. The market cap suggests moderate volatility, leading to a positive stock price movement prediction of 2% to 8% over the next two weeks.